Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Patients with severe obesity (BMI 40), significant comorbid metabolic disease, or family history of type 2 diabetes may benefit from maximum-dose targeting after appropriate titration
EMPOWER YOUR WILLPOWER - GLP-1 Probiotic is a multi-strain probiotic that empowers you to take control of your metabolic health by naturally increasing GLP-1,* the un-hunger hormone that sends a message to your brain that youre full
Tirzepatide: Some patients report slightly higher rates of GI symptoms, likely due to its dual mechanism
Live life Better
A heart disease study of semaglutide in patients with type 2 diabetes (SOUL, NCT03914326) evaluating the cardiovascular benefit of oral semaglutide is currently underway
It is important for researchers to initiate experiments with either peptide at a low dosage and gradually escalate the dose over time
US$ 24.64
US$ 26.97
US$ 22.51
)
US$ 21.19
